Follow
Ramy Hanna
Ramy Hanna
Assistant Professor at UCI
Verified email at uci.edu
Title
Cited by
Cited by
Year
A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease
RM Hanna, L Ghobry, O Wassef, CM Rhee, K Kalantar-Zadeh
Blood purification 49 (1-2), 202-211, 2020
3042020
Plant-dominant low-protein diet for conservative management of chronic kidney disease
K Kalantar-Zadeh, S Joshi, R Schlueter, J Cooke, A Brown-Tortorici, ...
Nutrients 12 (7), 1931, 2020
1992020
Burden of anemia in chronic kidney disease: beyond erythropoietin
RM Hanna, E Streja, K Kalantar-Zadeh
Advances in therapy 38 (1), 52-75, 2021
1852021
A case of novel coronavirus disease 19 in a chronic hemodialysis patient presenting with gastroenteritis and developing severe pulmonary disease
AJ Ferrey, G Choi, RM Hanna, Y Chang, E Tantisattamo, K Ivaturi, E Park, ...
American journal of nephrology 51 (5), 337-342, 2020
1622020
Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence
RM Hanna, M Barsoum, F Arman, U Selamet, H Hasnain, I Kurtz
Kidney international 96 (3), 572-580, 2019
972019
Distinguishing 3 classes of corpus callosal abnormalities in consanguineous families
RM Hanna, SE Marsh, D Swistun, L Al-Gazali, MS Zaki, GM Abdel-Salam, ...
Neurology 76 (4), 373-382, 2011
712011
Approach and management of hypertension after kidney transplantation
E Tantisattamo, MZ Molnar, BT Ho, UG Reddy, DC Dafoe, H Ichii, ...
Frontiers in Medicine 7, 229, 2020
682020
Advances in autosomal dominant polycystic kidney disease: a clinical review
N Nobakht, RM Hanna, M Al-Baghdadi, KM Ameen, F Arman, E Nobahkt, ...
Kidney medicine 2 (2), 196-208, 2020
612020
Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension
RM Hanna, EA Lopez, H Hasnain, U Selamet, J Wilson, PN Youssef, ...
Clinical kidney journal 12 (1), 92-100, 2019
612019
Minimal change disease onset observed after bevacizumab administration
RM Hanna, E Lopez, J Wilson, S Barathan, AH Cohen
Clinical Kidney Journal 9 (2), 239-244, 2016
452016
The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients
RM Hanna, WT Yang, EA Lopez, JN Riad, J Wilson
Clinical Kidney Journal 9 (4), 530-539, 2016
412016
Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
M Shye, RM Hanna, SS Patel, N Tram-Tran, J Hou, C Mccannel, M Khalid, ...
Clinical Kidney Journal 13 (6), 969-980, 2020
382020
Thrombotic microangiopathy and acute kidney injury induced after intravitreal injection of vascular endothelial growth factor inhibitors VEGF blockade-related TMA after …
RM Hanna, NT Tran, SS Patel, J Hou, KD Jhaveri, R Parikh, U Selamet, ...
Frontiers in Medicine 7, 579603, 2020
372020
Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab
RM Hanna, L Abdelnour, H Hasnain, U Selamet, I Kurtz
SAGE Open Medical Case Reports 8, 2050313X20907033, 2020
322020
Renal-cerebral pathophysiology: the interplay between chronic kidney disease and cerebrovascular disease
RM Hanna, A Ferrey, CM Rhee, K Kalantar-Zadeh
Journal of Stroke and Cerebrovascular Diseases 30 (9), 105461, 2021
292021
Acute kidney injury after pembrolizumab-induced adrenalitis and adrenal insufficiency
RM Hanna, U Selamet, P Bui, SF Sun, O Shenouda, N Nobakht, ...
Case Reports in Nephrology and Dialysis 8 (2), 171-177, 2018
272018
Calcium transport in the kidney and disease processes
RM Hanna, RS Ahdoot, K Kalantar-Zadeh, L Ghobry, I Kurtz
Frontiers in Endocrinology 12, 762130, 2022
242022
Equivalent efficacy and decreased rate of overcorrection in patients with syndrome of inappropriate secretion of antidiuretic hormone given very low-dose tolvaptan
RM Hanna, JC Velez, A Rastogi, MK Nguyen, MK Kamgar, K Moe, ...
Kidney medicine 2 (1), 20-28, 2020
202020
Prognostic nutritional index as a predictor of mortality in 101,616 patients undergoing hemodialysis
Y Miyasato, RM Hanna, J Morinaga, M Mukoyama, K Kalantar-Zadeh
Nutrients 15 (2), 311, 2023
182023
Thrombotic microangiopathy syndromes—Common ground and distinct frontiers
RM Hanna, K Henriksen, K Kalantar-Zadeh, A Ferrey, R Burwick, ...
Advances in chronic kidney disease 29 (2), 149-160. e1, 2022
182022
The system can't perform the operation now. Try again later.
Articles 1–20